Johnson and Johnson Newswire (Page 5)

Comprehensive Real-Time News Feed for Johnson and Johnson. (Page 5)

Results 81 - 100 of 15,464 in Johnson and Johnson

  1. VMWare pinches Juniper Networks CIORead the original story

    Wednesday Feb 25 | Aurora Era-Banner

    VMware has stolen the chief information officer of Juniper Networks after its own CIO Tony Scott took a job with US president Barack Obama . Bask Iyer will head up the virtualisation company's global information and technology department, having previously worked on IT for healthcare firms Johnson & Johnson and GlaxoSmithKline, as well as manufacturers Honeywell.

    Comment?

  2. Johnson & Johnson loses first Risperdal jury trialRead the original story w/Photo

    Wednesday Feb 25 | Philly.com

    A Philadelphia jury said Tuesday that drugmaker Johnson & Johnson should pay $2.5 million to a 20-year-old autistic man from Alabama - who developed size 46 DD breasts as a young teenager - because the company failed to adequately warn of that potential side effect from his use of the antipsychotic drug Risperdal. This was the first case related to the condition called gynecomastia that went to a jury, but thousands more lawsuits are lined up in Philadelphia, California, Missouri, and other locations.

    Comment?

  3. Biosimilar copies of blockbuster drug launch in major EU marketsRead the original story

    Wednesday Feb 25 | WNFL-AM Green Bay

    Cheap versions of a top-selling drug for rheumatoid arthritis and Crohn's disease are being launched across major European markets in an important advance for a new type of medicines known as biosimilars. The products from South Korean firm Celltrion and its partners Hospira and Mundipharma will compete with Remicade, the original branded drug from Johnson & Johnson and Merck & Co.

    Comment?

  4. Xarelto Lawsuit News: Bayer and Johnson & Johnson Pursue Additional...Read the original story

    Wednesday Feb 25 | Sys-Con Media

    According to Drug Watch, the announcement was made last month by Bayer and J&J, and they seek further federal approvals for Xarelto for stroke patients. The public announcement was made amidst the news that plaintiffs have continued to file lawsuits over the companies, and in December and January, judges both in consolidated cases into multidistrict litigation as well as a mass tort program.

    Comment?

  5. Keep It SimpleRead the original story w/Photo

    Wednesday Feb 25 | Seeking Alpha

    A design/engineering principle noted by the US Navy in 1960, it's an acronym that originally stood for: Keep it simple, stupid. You can use another variation of it that is perhaps less offensive, like keep it simple and straightforward.

    Comment?

  6. One Man's OpinionDID Middle East Meeting Bomb on Broadway?Read the original story

    Tuesday Feb 24 | American Reporter

    Nineteen-thirty-five was not that great a year for America. The country was still in the Depression.

    Comment?

  7. Man, 20, awarded $2.5M in damages after drug gave him big boobsRead the original story w/Photo

    Tuesday Feb 24 | Philly.com

    AN ALABAMA man who grew enormous breasts after taking an antipsychotic drug as a boy was awarded $2.5 million in damages in a Philadelphia court yesterday against the Johnson & Johnson subsidiary that makes the pill. A Common Pleas jury concluded that Austin Pledger, now 20, "was not adequately warned" that he would grow size 46DD breasts as a side effect of using Risperdal, produced by Janssen Pharmaceuticals, according to his lawyer, Thomas Kline.

    Comment?

  8. DGI Portfolio Update - Being Patient Is Frustrating To New InvestorsRead the original story w/Photo

    Tuesday Feb 24 | Seeking Alpha

    In December, I detailed the start of a new DGI Portfolio . As a recap, I have 30+ years to retirement and I had dedicated 33% of my portfolio to a DGI strategy.

    Comment?

  9. Risperdal Lawyers at Bernstein Liebhard LLP Comment on Today's $2.5 ...Read the original story w/Photo

    Tuesday Feb 24 | PRWeb

    The Firm is representing numerous gynecomastia plaintiffs who have Risperdal lawsuits pending in the same mass tort litigation. As a bellwether case, this Risperdal trial was intended to provide insight into how juries might rule in similar claims involving male breast growth.

    Comment?

  10. Retirement Strategy: Adding A Stock That Acts More Like A Snail But Is A Dividend ChampionRead the original story w/Photo

    Tuesday Feb 24 | Seeking Alpha

    Sometimes it is a good idea to add a boring slow moving stock that has a good dividend history for immediate income. The Frothy Market Beginner's Portfolio does not always need a dividend aristocrat, mega cap blue chip stock to feel more secure and add income.

    Comment?

  11. Mondelez names EVP and president for North AmericaRead the original story w/Photo

    Tuesday Feb 24 | Snack Food/Wholesale Bakery

    Mondelez International, Deerfield, IL, has named Roberto Marques executive vice president and president, North America. Based in East Hanover, NJ, he will be responsible for leading the company's $7 billion business in the U.S. and Canada, which includes brands like Oreo and belVita biscuits and Triscuit and Wheat Thins crackers.

    Comment?

  12. Mondelez International names Roberto Marques executive v.p. and president, North AmericaRead the original story w/Photo

    Tuesday Feb 24 | Candy Industry

    Mondelez International has announced that Roberto Marques, formerly of Johnson & Johnson, will join the company mid-March as executive v.p. and president, North America. Marques, 49, succeeds Mark Clouse, who became the company's chief growth officer in July 2014, and will report to Chairman and CEO Irene Rosenfeld.

    Comment?

  13. The 5 Anti-Gay Boycotts That Failed SpectacularlyRead the original story w/Photo

    Sunday Feb 22 | Unicorn Booty

    Faith2Action spokeswoman and modern day Mean Girl Janet Porter won't be using Tylenol to cure her headache, arthritis, cold and flu and sleeplessness anytime soon. Angered over the presence of a lesbian couple in a December 2014 Tylenol commercial, Porter called for a boycott of the popular headache remedy.

    Comment?

  14. J&J ordered by jury to pay $2.5 million over antipsychotic drugRead the original story w/Photo

    Tuesday Feb 24 | The Verona-Cedar Grove Times

    A jury ordered Johnson & Johnson to pay $2.5 million to the family of an autistic man who developed female breasts while taking the company's Risperdal antipsychotic drug, in the first verdict in thousands of lawsuits filed over the medication's side effect.

    Comment?

  15. Mondelez Names Marques EVP and President for North AmericaRead the original story w/Photo

    Tuesday Feb 24 | CSP

    Mondelez International, a leading maker of biscuits, chocolate, gum and candy, has announced that Roberto Marques, 49, will join the company in mid-March and become executive vice president and president for North America. Marques succeeds Mark Clouse, who became the company's Chief Growth Officer in July 2014.In this role, he will be responsible for leading the company's $7 billion business in the United States and Canada, which includes Oreo and belVita biscuits, Triscuit and Wheat Thins crackers, Halls candy and Trident gum.

    Comment?

  16. Johnson & Johnson Has A Potential Buyer For Its Medical Devices UnitRead the original story w/Photo

    Tuesday Feb 24 | GuruFocus.com

    The well acclaimed pharmaceutical and healthcare giant, Johnson & Johnson , has been in the news ever since August of last year when it expressed its interest to divest the medical devices unit from its core business stream. In fact, the medical devices unit has not seen much of a profit in the past few quarters and has dragged the top and bottom line of Johnson & Johnson in the past fiscal year.

    Comment?

  17. Westport bets on Milpitas with $45M campus buy from J&JRead the original story

    Tuesday Feb 24 | Business Journal

    With its $45.25 million purchase of a vacant, 400,000-square-foot office park near the Great Mall, Westport Capital Partners LLC is betting that Milpitas is in line to land new and expanding tech tenants. "We think we can take it and make it a very modern, R&D office opportunity for tenants in today's marketplace," Eric Clapp , managing director for Westport Capital Partners, said in a phone call.

    Comment?

  18. Joan C. Winterbottom Joins Argos Therapeutics, Inc. As Chief Human Resources OfficerRead the original story

    Monday Feb 23 | BioSpace

    Argos Therapeutics Inc. , a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer based on the ArcelisA technology platform, today announced that Joan C. Winterbottom will join the company as chief human resources officer. Ms. Winterbottom has 14 years of experience in human resources in the pharmaceutical and biotechnology industries.

    Comment?

  19. Implants 'as dangerous as asbestos'Read the original story w/Photo

    Tuesday Feb 24 | BBC News

    He was lead trial counsel in the first pelvic mesh trial against Johnson & Johnson and Ethicon, resulting in a compensatory and punitive damages verdict of $11.1m. Giving evidence to members of the Scottish Parliament committee via videoconference, Mr Slater said the closest comparison to the mesh implant situation he could think of was asbestos.

    Comment?

  20. It's Not Sexy, But I Am Buying Johnson & JohnsonRead the original story w/Photo

    Tuesday Feb 24 | Seeking Alpha

    I am in the process of evaluating several stocks to be added to my Dividend Dreams Portfolio . I am doing so because I am changing jobs in the next few weeks and rolling my 401k over to an IRA.

    Comment?